Infections resulting from surgery are a major concern in healthcare, and it’s been addressed here several times already. The economic aspect of these infections has been difficult to pin down, though. A new study sought to estimate the per-patient cost of the infections, and the amount is staggering.
The study, which was conducted by researchers at Duke, followed hundreds of patients in the 9o days following surgery. Patients who contracted MRSA infections accrued additional costs of around $60,000 for the three additional weeks of hospitalization they required, on average, to clear the infection. In that same 90 day period, the MRSA infected patients were seven times likelier to die than other patients, the study says. At just the seven hospitals that the study investigated, the MRSA infections accounted for more than $19 million in additional costs. These stats remind us once again that preventing MRSA-related infections in hospitals can save us not only unnecessary deaths, but also significant amounts of money.
Read more about the study here.



